Association of White Matter With Core Cognitive Deficits in Patients With Schizophrenia

Aging and Cognitive FunctionsPsychosis and Schizophrenia

Obesity influences white matter integrity in schizophrenia

Psychoneuroendocrinology.

Spangaro M, Mazza E, Poletti S, Cavallaro R, Benedetti F

doi: 10.1016/

Aging and Cognitive FunctionsPsychosis and Schizophrenia

Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits.

Psychol Med.

Chen DC, Du XD, Yin GZ, Yang KB, Nie Y, Wang N, Li YL, Xiu MH, He SC, Yang FD, Cho RY, Kosten TR, Soares JC, Zhao JP, Zhang XY

Bipolar Disorder

Effects of illness duration on cognitive performances in bipolar depression are mediated by white matter microstructure

doi: 10.1016/j.jad.2019.02.015.

Aging and Cognitive FunctionsPsychosis and Schizophrenia

Cognitive performance is associated with gray matter decline in first-episode psychosis

Psychiatry Res.

Dempster K, Norman R, Théberge J, Densmore M, Schaefer B, Williamson P

doi: 10.1016/

Aging and Cognitive Functions

Chemotherapy-induced cognitive impairments: White matter pathologies

Cancer Treat Rev.

Matsos A, Loomes M, Zhou I, Macmillan E, Sabel I, Rotziokos E, Beckwith W, Johnston IN

doi: 10.1016/j.ctrv.2017.09.010.

Multiple Sclerosis

Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis

Neurology.

Gaetano L, Häring DA, Radue EW, Mueller-Lenke N, Thakur A, Tomic D, Kappos L, Sprenger T

doi: 10.1212/WNL.

Aging and Cognitive FunctionsPsychosis and Schizophrenia

A systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits

Transl Psychiatry.

Habtewold TD, Rodijk LH, Liemburg EJ, Sidorenkov G, Boezen HM, Bruggeman R, Alizadeh BZ

doi: 10.1038/s41398-020-00919-x.

RECOMMENDED

Psychosis and Schizophrenia

White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study

Mol Psychiatry.

Cetin-Karayumak S, Di Biase MA, Chunga N, Reid B, Somes N, Lyall AE, Kelly S, Solgun B, Pasternak O, Vangel M, Pearlson G, Tamminga C, Sweeney JA, Clementz B, Schretlen D, Viher PV, Stegmayer K, Walther S, Lee J, Crow T, James A, Voineskos A, Buchanan RW, Szeszko PR, Malhotra AK, Hegde R, McCarley R, Keshavan M, Shenton M, Rathi Y, Kubicki M

doi: 10.1038/s41380-019-0509-y.

Parkinson’s Disease

White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease

Neurology.

Bledsoe IO, Stebbins GT, Merkitch D, Goldman JG

doi: 10.1212/WNL.

Related content

Obesity influences white matter integrity in schizophrenia

Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits.

Effects of illness duration on cognitive performances in bipolar depression are mediated by white matter microstructure

Cognitive performance is associated with gray matter decline in first-episode psychosis

Chemotherapy-induced cognitive impairments: White matter pathologies

Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis

A systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits

White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study

White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease